Primoris develops 'Delivery Platform can load Effective Substance' and 'Function-enhanced Exosome medicine' with using Nanovesicle from Stem cells
Company Details
- Employees
- 2
- Founded
- -
- Address
- #1504, A Bidg., 60 Haan-Ro, Gwangmyeong-Si, Gyeonggi-Do 14322, Korea, Gwangmyeong City,korea, Republic Of
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.primoris.co.kr/
- Keywords
- Exosome, Stem cells, mRNA, Nanovesicle, Delivery Platform, R&D, Bio, Pharmaceutical, Business development, 바이오벤처, 엑소좀, 줄기세포, 나노소포체, 플랫폼, 전달 플랫폼, 운반 플랫폼, 항암, 탈모치료제, 항암제, 상처치료제, 폐렴치료제, 엑소좀 의약품, 의약품, Exosome medicine, Nanovesicle Medicine, 약물 전달 플랫폼, Korea, K bio, Drug Delivery Platform, Platform, seriesA, Investment.
- HQ
- Gwangmyeong City
Primoris Co., Ltd. Questions
Primoris Co., Ltd.'s website is http://www.primoris.co.kr/
Primoris Co., Ltd.'s LinkedIn profile is https://kr.linkedin.com/company/primoris-co-ltd
Primoris Co., Ltd. has
2 employees.
View email and phone details for 2
employees at Primoris Co., Ltd..
Primoris Co., Ltd.'s industry is
Biotechnology Research
Primoris Co., Ltd.'s top competitors are
Asiabnc Corp.,ltd,
Kangstem Biotech Co., Ltd.,
Unimed Shpk,
Volhartmetal Recycling,
Jlmk Ltd Health & Beauty,
Pharmaresearch Co. Ltd.,
Abio Materials,
Primoris International Co., Ltd.,
Zirna Doo,
Vitamer.
Primoris Co., Ltd.'s categories are Biotechnology Research
Primoris Co., Ltd.'s founding year is 2019
